U.S. joins a lot of the world in acknowledging medical marijuana
The U.S. has joined a lot of the world in acknowledging medical marijuana. Let worldwide buying and selling start!
Efficient April 22, 2026, the Lawyer Basic “hereby order[s] that FDA-approved drug merchandise containing marijuana, as nicely marijuana in any kind lined by a state medical marijuana license, be positioned in schedule III of the CSA.” Based mostly on this order, america acknowledges medical marijuana and has a completely functioning medical marijuana program (by way of state licensees). The ultimate order applies to: (a) marijuana as listed in 21 CFR 1308.11(d)(23), (b) marijuana extracts as outlined in 21 CFR 1308.11(d)(58), and (c) naturally occurring Delta-9-THC derived from the marijuana plant (aside from the mature stalks and seeds). The order does not reschedule all marijuana. Any marijuana or marijuana extract not lined by this order (i.e. state-legal adult-use marijuana) stays in schedule I and might be topic to a brand new rescheduling listening to scheduled for June 29, 2026 at 9 a.m. ET.
This order went a lot additional than anticipated. I wrote final yr concerning the limits of shifting marijuana to schedule III, and the way such a transfer wouldn’t legalize state-licensees with out regulatory change. This order does simply that. It amends DEA rules to legalize state licensees. Whether or not such amendments will face up to judicial scrutiny stays to be seen.
How the order was issued
As I wrote about beforehand, all it took to reschedule was a press launch and stroke of a pen. Though, it was not a lot a stroke of a pen as a 23-page order outlining the present transfer and future course of. This transfer doesn’t seem to position marijuana in Schedule III; somewhat, it locations sure formulations of marijuana in schedule III–specifically FDA authorised merchandise and, extra impactfully, medical marijuana merchandise that “are topic to a state-issued license to fabricate, distribute, and/or dispense marijuana merchandise containing marijuana for medical functions.”
It is very important be aware that this can be a last order being issued underneath 21 USC 811(d)(1) and never a proposed rule. Part 811(d)(1) permits the Lawyer Basic to reschedule a substance if doing so would place the U.S. in higher alignment with its worldwide treaty obligations. I’ve written about this many instances through the years, and supplied place papers to DEA on using this mechanism. Utilizing 811(d)(1), the DOJ and DEA should not required to acquire a suggestion from HHS, although one was supplied in 2023.
In its order, DEA additionally takes pains to focus on the HHS findings in its 2023 suggestion, supporting right this moment’s transfer, though such assist shouldn’t be wanted. The appearing Lawyer Basic acknowledged that “[a]lthough I’m not required to think about this HHS suggestion when issuing an order underneath part 811(d)(1), as a result of I consider there are a number of legally viable scheduling choices that might fulfill america’ obligations underneath the Single Conference . . . . I train my discretion in figuring out probably the most acceptable schedule by selecting the choice that the majority carefully aligns to HHS’s findings and greatest place america to hold out its obligations underneath the Single Conference.”
Registration necessities
State-licensed medical marijuana operators
The ultimate order establishes an expedited registration course of underneath 21 CFR 1301 for state-licensed medical marijuana entities to register for a DEA license to fabricate, distribute, and dispense marijuana for medical functions underneath federal legislation. Which means state licensed medical marijuana operators might be permitted to use for DEA registrations, one thing DEA has prohibited previously.
The Lawyer Basic decided that state-licensed regulatory programs have developed sturdy infrastructure for stopping diversion, guaranteeing product security, correct document retention, and correct facility inspections, all of which fulfill the goals of federal registration and recordkeeping necessities. Taken as an entire, these programs “show a sustained capability to realize the public-interest goals that underlie the CSA’s registration framework, together with defending public well being and security and stopping the diversion of managed substances into illicit channels.” As such, the Lawyer Basic decided that “incorporating state licensing programs into the federal registration framework represents the best and environment friendly technique of attaining the CSA’s goals.” The Lawyer Basic and DEA protect authority, nevertheless, to disclaim or revoke registration the place particular public curiosity considerations come up, and to make sure compliance with the Single Conference.
Based mostly on this state-federal partnership, DEA will amend half 1301 of its rules to supply an expedited overview course of underneath which state licensees could submit their current state credentials as conclusive proof of state authorization to obtain DEA registration for manufacturing, distribution, and dispensaries. Importantly, the DEA should grant registration except doing so can be inconsistent with the general public curiosity underneath 21 USC 823 components or underneath the Single Conference. Purposes submitted inside 60 days of publication have to be processed inside six months, and early candidates could lawfully function underneath their state-issued license through the pendency of overview.
State registrants may depend on state-law labeling, packaging, disposal, and bodily safety necessities in lieu of the federal necessities, topic to inclusion of the statutory warning label required by 21 USC 825(c).
FDA-approved marijuana operators
The next outlines the schedule III regulatory necessities that now apply “for individuals who deal with marijuana completely within the type of an FDA-approved drug product”:
Any one who handles FDA-approved drug merchandise containing marijuana have to be registered with the DEA to conduct such actions for a schedule III substance.
Entities that switch marijuana to sufferers, together with dispensaries, should register with the DEA as “practitioners” underneath 21 USC 823(g).
Schedule III FDA-approved drug merchandise containing marijuana have to be disposed of in accordance with 21 CFR 1317, along with different relevant state and federal necessities.
DEA registrant candidates should pay the annual DEA payment for registration, that are: (1) Producer: $3,999 yearly; (2) Distributors: $1,850 yearly; and (3) Dispensaries, together with pharmacies: $888 for a registration legitimate for 3 years.
Prescriptions are required to be issued previous to allotting FDA authorised marijuana medication and should include particular info.
All DEA registrants should keep data as required by federal legislation and submit stories with respect to FDA-approved medication.
All DEA registrants should adjust to DEA safety necessities, labeling and packaging, and stock necessities.
Worldwide commerce and import/export and DEA authority
Imports and exports
As I’ve argued together with colleagues, this transfer to schedule III may even require amending DEA’s rules to account for US obligations underneath the Single Conference with marijuana being moved into Schedule III. In DOJ’s last order, it acknowledged the identical, stating that “DEA should concurrently amend the rules to require a allow to import or export such merchandise.”
This order particularly states that “this order amends the DEA rules (21 CFR 1312.30) so as to add FDA-approved drug merchandise containing marijuana and state-licensed medical marijuana to the listing of nonnarcotic schedule III by means of V managed substances which are topic to the import and export allow requirement.” Registering with the DEA will permit state licenses to doubtlessly entry the worldwide market, as DEA registrants can apply for and obtain import and export licenses. One other vital modification is that DEA addressed its regulatory definition of “medicinal hashish,” which DEA created out of skinny air, to exempt state authorized medical marijuana from the requirement that medicinal hashish be FDA authorised and authorized to market underneath the Meals, Drug, and Beauty Act.
DEA will grow to be part of the state medical marijuana provide chain
Registration with the DEA might be important for state medical marijuana licensees, as a result of DEA might be answerable for buying and promoting the marijuana grown by state licensees as required by DEA’s rules and the Single Conference. “By sustaining in schedule I all unlicensed marijuana, bulk marijuana, and any marijuana or marijuana extract that has not but been integrated right into a FDA-approved drug product, and by requiring that state-licensed marijuana fulfill the necessities referring to the acquisition and sale of marijuana by DEA, america will proceed to satisfy these obligations with out disruption or delay.”
The rule additionally establishes a nominal value purchase-and-resale mechanism by means of which the DEA acquires and resells registered producers’ marijuana crops, to fulfill Single Conference necessities. Question: do we actually anticipate DEA to take possession of all flower gross sales inside state programs? Because the order is written, registered producers should retailer crops in DEA maintained services till the transaction is full, and every registrant should present DEA info on the precise location the place medical marijuana is cultivated.
Analysis
Researchers who receive marijuana or marijuana derived merchandise from state licensees to be used in scientific analysis are shielded from civil and prison legal responsibility underneath the CSA, supplied that the researcher is registered with the DEA. This now permits for state medical marijuana and merchandise to be researched.
I.R.C. 280E
The order acknowledges that state medical licensees will not be topic to I.R.C. 280E, however doesn’t make a dedication on their tax standing and suggests they converse to a tax guide when making their tax dedication. It goes on additional to encourage the “Secretary of Treasury to think about offering retrospective aid from Part 280E legal responsibility for taxable years wherein a state licensee operated underneath a state medical marijuana license.” Importantly, 280E will doubtless be a nightmare for these working in twin licensing states the place each adult-use and medical typically function underneath as soon as license. Many operators, together with the big multi-state operators, don’t maintain distinct data. Since solely licensed medical operations qualify for 280E aid, except these firms can separate their books–and in some instances their licenses–they may doubtless stay topic to 280E.
What the order doesn’t cowl
This order doesn’t apply to: (1) something that doesn’t fall into the FDA-approved marijuana; (2) any merchandise and operators not licensed by a state’s medical marijuana program; (3) synthetically derived THC (e.g. delta-10 THC) which stays in schedule I; and (4) Any hemp product exceeding 0.4mg after November twelfth. Anybody coping with non-FDA authorised medical marijuana or state licensed medical marijuana will stay in violation of federal legislation because it pertains to a schedule I managed substance.
It seems that present DEA registrants manufacturing bulk marijuana may even stay in Schedule I, since they’re neither FDA authorised nor legalized underneath state authorized medical marijuana applications.
Excellent points
Some excellent questions stay. As an example, as a talk about above re: 280E, how will twin licensees that present each adult-use and medical marijuana be handled? For instance, in Arizona marijuana bought as adult-use or medical shouldn’t be designated as such till the purpose of sale. How will medical marijuana versus the adult-use be tracked for schedule III, and extra importantly, 280E functions? One factor is probably going sure: these working in these twin licensed states that comingle medical and adult-use marijuana (whether or not by means of stock or by way of the corporate’s books) will nearly actually be ineligible for the early expedited DEA registration mentioned above.
Upcoming DEA administrative legislation listening to
The Lawyer Generals order doesn’t reschedule all marijuana. Something not included on this order might be topic to a brand new administrative legislation listening to, which is scheduled to start on June 29, 2026, at 9 a.m. ET. The results of this listening to will decide whether or not all “marijuana” is moved into schedule III.
Sure authorized challenges
DEA does acknowledge in footnote thirty-nine that if any of the order is discovered unlawful, the remainder of the provisions shall stay. This acknowledges the fact that litigation will definitely ensue–if it hasn’t already. Sensible Approaches to Marijuana will definitely carry litigation difficult the Lawyer common and DEA’s authority to challenge this order and the foundations associated to it. Whereas the Lawyer Basic’s Authority to reschedule a substance underneath 811(d)(1) is obvious, its potential to amend operational and registration rules underneath the identical authority shouldn’t be as clear. We might be maintaining an in depth eye on this as issues progress and can publish updates as they happen.
Within the meantime, in case you are a state licensed medical marijuana operator, please don’t hesitate to achieve out to our staff about DEA registration. Additional, in case you are a international medical marijuana operator seeking to discover US alternatives, they lastly exist (at the very least for now).
____
For earlier insights on marijuana rescheduling, please try these weblog posts:
